Dynamic Changes and Function of Protease Inhibitors:-α<SUB>1</SUB>-Antitrypsin and α<SUB>2</SUB>-Macroglobulin-
スポンサーリンク
概要
- 論文の詳細を見る
Among several protease inhibitors (PI) in the body, α<SUB>1</SUB>-antitrypsin (α<SUB>1</SUB>AT) and α<SUB>2</SUB>-macroglobulin (α<SUB>2</SUB>MG) are supposed to be the major with regard to their plasma concentration and activities. Though these PI are able to inhibit several proteases in the body such as plasmin or trypsin in vitro, their physiological function in serum are unknown. Furthermore, it is not clear why there is an increase of these proteins in certain physiological and pathological conditions. Recently proteolytic enzymes such as thrombin or neutral proteases derived from polymorphonuclear leukocytes has been demonstrated on the surface of lymphocytes and also shown to be capable of inducing mitogenesis in lymphocytes. Further, the presence of α<SUB>1</SUB>AT or α<SUB>2</SUB>MG have been demonstrated on lymphocytes.<BR>The present study was performed firstly to know the fate of these PI in the body which were raised by inflammation or tumor bearing. Secondary, the possible mechanism that the control of proteolytic activity may be involved in the regulation of lymphocyte blastogenesis was studied. As a results, imrnunoregulatory effect of α<SUB>2</SUB>MG has been proposed.<BR>Upon turpentine injection serum α<SUB>1</SUB>AT rapidly increased to the maximum, which being 1.7 times that of normal control, within 24hr in rats. α<SUB>2</SUB>MG increased to maximum value of about 400mg/dl between 24 and 72 hr after turpentine injection. This maximum value is calculated to be about 100 times that of normal control.<BR>Radiolabeled α<SUB>1</SUB>AT and α<SUB>2</SUB>MG were administered intravenously into the rats bearing inflammatory granuloma or sarcoma and their distributi0ns into various tissues were examined as a function of time. Considerable amount of α<SUB>1</SUB>AT remained in blood for 24hr, while very few amount of α<SUB>2</SUB>MG and its degradation products were found in the circulation at 6hr after administration. It may be presumed from this result that intravenously administered α<SUB>2</SUB>MG was rapidly degraded and disappeared from circulation. α<SUB>1</SUB>AT accumulated to a higher extent and persisted longer in the tumor or inflammatory tissues than in any other normal tissues during 72 hr period. Similar results were obtained in the case of α<SUB>2</SUB>MG though the level of the protein in the tissues were much lower than those of α<SUB>1</SUB>AT.<BR>Among normal tissues examined, the highest distribution of α<SUB>1</SUB>AT was found in lung, followed by kidney, muscle, spleen and liver in that order. Considering the anatomical characteristics of the lung that this organ is directly open to outside environment being exposed to the toxic agents and that severe tissue destructions are seen in patients with α<SUB>1</SUB>AT deficiency, the accumulation of al AT in lung may be expected to prevent the tissue damage. The distribution of α<SUB>2</SUB>MG into normal tissues were far low compared to α<SUB>1</SUB>AT and little differences were observed among each tissue. These results suggest that α<SUB>1</SUB>AT and α<SUB>2</SUB>MG may play some roles in the site of inflammation or tumor tissues to regulate inflammatory processes or tumor proliferation. α<SUB>1</SUB>AT would preferably act in the tissue while α<SUB>2</SUB>MG in the circulation.<BR>The influence of PI on the immune reaction system was examined in vitro using lymphocytes culture. Con A or PHA induced lymphocyte blastogenesis was inhibited by addition of α<SUB>2</SUB>MG in the culture medium. This inhibition was not observed when the concentration of α<SUB>2</SUB>MG in culture was physiological level, while remarkable inhibition was occurred when the protein concentration increased up to the serum level in rats with inflammation.
- Japan Society of Clinical Chemistryの論文
著者
-
津田 和矩
宮崎医科大学第二内科
-
石橋 大海
九州大学医学部第1内科
-
工藤 二郎
九州大学医学部第一内科
-
大久保 英雄
九州大学医学部第一内科
-
活田 融
九州大学医学部第一内科
-
宮永 修
九州大学医学部第一内科
-
柴田 勝紀
九州大学医学部第1内科
-
津田 和矩
宮崎医科大学医学部第2内科
-
工藤 二郎
九州大学医学部第1内科
-
大久保 英雄
九州大学医学部第1内科
-
宮永 修
九州大学医学部第1内科
関連論文
- 307 ヤケヒョウヒダニ虫体抗原に対する気管支喘息患者の免疫応答の研究(3) : リンパ球増殖反応におけるHLA class II抗原の役割
- ヤケヒョウヒダニ虫体抗原に対する気管支喘息患者の免疫応答
- 187 ヤケヒョウヒダニ虫体アレルゲンに対する気管支喘息患者の免疫応答の研究(2)
- 366 ヤケヒョウヒダニ虫体精製抗原に対する気管支喘息患者の免疫応答の研究(1)
- 超音波検査が有用であった腹壁ヘルニア
- 悪性貧血を合併した原発性胆汁性肝硬変の1例
- 特発性血小板減少性紫斑病,急性間質性肺炎に併発した胆管炎の1例
- 特異な超音波像を呈した自己免疫性胆管炎の1例
- 原発性胆汁性肝硬変に肝内胆管癌を合併した1例
- 自然経過を画像にて追跡しえた自己免疫性膵炎の1例
- C型慢性肝炎を伴う非アルコール性晩発性皮膚ポルフィリン症にみられた限局性脂肪肝
- 潰瘍性大腸炎へのカラードプラ法の応用
- 7年間経過観察したGastric Antral Vascular Ectasia(GAVE)合併原発性胆汁性肝硬変症の1症例
- 表面型早期胆嚢癌の1症例 : 超音波カラードプラ法の適用
- クローン病の1症例 : 活動性指標としての超音波カラードプラ法の有用性
- S状結腸間に瘻孔形成を認めた潰瘍性大腸炎の1症例
- インターフェロン投与早期に扁桃周囲膿瘍より頸部膿瘍へと進展し, 敗血症を呈した慢性C型肝炎の1例
- 慢性C型肝炎へのインターフェロン治療後に再生不良性貧血,肝細胞癌を合併した肝硬変の1例
- 肝内門脈瘤と一過性亜区域性脂肪肝を合併した胆管細胞癌と考えられる1症例
- サイトメガロウィルスとの2重感によりキャリア化した急B型肝炎の1症例
- 遺伝的保因者
- D-ガラクトサミン肝障害の発生機序に関する研究
- IgA単独欠損症に全身性エリテマトーデスが発症した1例
- Amyloid A (AA)蛋白・原発性アミロイドーシスの1例
- Crigler-Najjar症候群II型の1例
- 下大静脈閉塞を伴うBudd-Chiari症候群を併発し,肝性脳症にて死亡したsystemic lupus erythematosusの1剖検例
- 新しい変異型α1-antitrypsin欠損症(PiMnichinan)の1家系特に肝細胞内に認めたdiastase抵抗性PAS染色陽性顆粒に関して
- 病初期より免疫異常,肝組織像の推移を追跡した橋本病合併ルポイド肝炎の一例
- 中脳への腫瘍塞栓により多食症をきたした原発性肝細胞癌の1剖検例
- 瀉血療法が有効であった晩発性皮膚ポルフィリン症の1例
- 妊娠の経過中に発症したBudd-Chiari症候群の1症例
- 筋肉病変とdisseminated intravascular coagulationを呈したcytophagic histiocytic panniculitisの1例
- Bence-Jones型多発性骨髄腫にみられた免疫グロブリン低下の機序
- 2種の副腎皮質ステロイド製剤で,重篤なアナフィラキシー様ショックをきたした気管支喘息の1例
- 初期肝硬変を発症した遺伝性α1-antitrypsin 欠損症の1例
- 晩発性皮膚ポルフィリン症を合併したC型慢性肝炎の1例
- 小腸・後腹膜転移を来した肝細胞癌の1例
- 胆嚢癌合併先天性胆道拡張症の術後に肝inflammatory pseudotumorを併発した1例
- ciclosporinが奏効した難治性潰瘍性大腸炎の1例
- 黄疸を伴わずに血清 CA19-9, SPAN 1の著明な増減を繰り返した肝内胆管結石症の1例
- 急性膵炎を合併した潰瘍性大腸炎の1例
- 胃癌の併発をみた男性ルポイド肝炎の一例
- 特発性気腹の1例
- クローン病の経過中に続発性アミロイドーシスを合併した1例
- Diphenylhydantoin長期投与例にみられたB cell不全によるhyper-IgM immunodeficiencyの1例
- Ulcerative colitis associated with pyoderma gangrenosum and schizophrenia. A case report.
- Abnormalities of B cell, helper T and suppressor T cell functions in a patient with common variable hypogammaglobulinemia
- Glucosamine-6-P Synthetase and UDP-GlcN Ac 2'-epimerase Activities in Tumor-bearing Animals
- N-Acetylneuraminic Acid Synthesis in Diabetic and Adrenalectomized Rats
- Dynamic Changes and Function of Protease Inhibitors:-α1-Antitrypsin and α2-Macroglobulin-
- TUBERCULOUS PERITONITIS:ANALYSIS OF 6 CASES
- On a mechanism of low level of Ig in a patient with multiple myeloma
- A New Deficient Variant of α1-Antitrypsin (Pi MNichinan) Discovered in Nichinan City, Miyazaki Prefecture
- Intravariceal tumor thrombi formation in hepatocellular carcinoma. A case report.
- A case of common variable immunodeficiency:hyperfunction of suppressor T cell
- 吸引生検により皮膚転移を生じた肝細胞癌の1例
- 猫蛔虫内臓幼虫移行症の肝内好酸球性肉芽腫を各腫画像診断にて解析し得た例
- Symposium on mechanisms of host defense from fundamental and clinical medicine. 1. Serum proteins and bioregulation.
- タイトル無し
- タイトル無し
- Idiopathic portal hypertension associated with intrahepatic portal aneurysm and splenic artery aneurysm. A case report.:a case report
- A case of adrenal myelolipoma.
- 多彩な腸管病変を合併したクローン病の1例
- Abnormalities of IgA specific B cell and suppressor T cell functions in a patient with selective IgA deficiency and systemic lupus erythematosus
- インターフェロン治療中に種の不整脈を発生したC型慢性活動性肝炎の1例
- SUMMARY
- Acute phase proteins